Aeternum HEALTH, Inc. (AETN) intrinsic value & 10-year financials
Aeternum HEALTH, Inc. (AETN) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 244.1% a year to $203.7K, with an average return on invested capital of 21.4%.
- Graham intrinsic value
- —
- Revenue (FY2025)
- $203.7K
- Revenue growth (10-yr CAGR)
- 244.1%
- ROIC (10-yr avg)
- 21.4%
- Free cash flow (FY2025)
- —
AETN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $203.7K | -$337.1K | -$0.01 | — | -132.2% | 18.3% |
| FY2024 | $65.1K | -$450.3K | -$0.01 | — | -661.1% | 31.0% |
| FY2023 | $20.1K | -$632.9K | -$0.01 | — | -2746.8% | 123.4% |
| FY2022 | $5.0K | -$2.1M | -$0.36 | — | -6080.7% | 27.2% |
| FY2021 | — | -$26.5K | $0.00 | — | — | 1.1% |
| FY2020 | — | -$41.4K | — | — | — | 1.7% |
| FY2019 | — | -$61.1K | — | — | — | 2.6% |
| FY2018 | $0 | -$52.5K | -$0.01 | — | — | 2.3% |
| FY2017 | $0 | -$61.1K | -$0.02 | — | — | 2.7% |
| FY2016 | $0 | -$83.2K | -$0.02 | — | — | 3.8% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
AETERNUM HEALTH, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
AETERNUM HEALTH, INC. has earned high returns on invested capital, averaging 21.4% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
AETERNUM HEALTH, INC. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, AETERNUM HEALTH, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.33 per share.